Albertsons Companies, Inc. (ACI)

[biotech_researcher]

Raises earnings guidance for 2022… Essentially now $3.00 per share!

Albertsons beats by $0.20, beats on revs; raises FY22 EPS above consensus
Reports Q3 (Nov) earnings of $0.79 per share, $0.20 better than the S&P Capital IQ Consensus of $0.59; revenues rose 8.6% year/year to $16.73 bln vs the $16.04 bln S&P Capital IQ Consensus.
Co issues upside guidance for FY22, sees EPS of $2.90-2.95 vs. $2.62 S&P Capital IQ Consensus (previously $2.50 to $2.60 per share).
Identical sales in fiscal 2021 in the range of (0.8%) to (1.2%) (previously (2.5%) to (3.5%)), representing two-year stacked growth of 15.7% to 16.1% (previously 13.4% to 14.4%).